نتایج جستجو برای: 52 high week

تعداد نتایج: 2230247  

Journal: :American journal of ophthalmology 2013
David M Brown Jeffrey S Heier W Lloyd Clark David S Boyer Robert Vitti Alyson J Berliner Oliver Zeitz Rupert Sandbrink Xiaoping Zhu Julia A Haller

PURPOSE To evaluate intravitreal aflibercept injections (IAI; also called VEGF Trap-Eye) for patients with macular edema secondary to central retinal vein occlusion (CRVO). DESIGN Randomized controlled trial. METHODS This multicenter study randomized 189 patients (1 eye/patient) with macular edema secondary to CRVO to receive 6 monthly injections of either 2 mg intravitreal aflibercept (IAI...

2016
M. Odawara J. Miyagawa N. Iwamoto Y. Takita T. Imaoka T. Takamura

AIMS To examine the efficacy and safety of once-weekly dulaglutide 0.75 mg monotherapy compared with once-daily liraglutide 0.9 mg in Japanese patients with type 2 diabetes (T2D) for 52 weeks. METHODS We conducted a phase III, randomized, 52-week (26-week primary endpoint), active- and placebo-controlled trial comparing 492 Japanese patients (dulaglutide, n = 281; liraglutide, n = 141; and pl...

2017
Gerd R Burmester William F Rigby Ronald F van Vollenhoven Jonathan Kay Andrea Rubbert-Roth Ricardo Blanco Alysha Kadva Sophie Dimonaco

OBJECTIVE Investigate whether the efficacy and safety of intravenous tocilizumab (TCZ) demonstrated at week 52 in patients with early rheumatoid arthritis (RA) are maintained to week 104. METHODS Methotrexate (MTX)-naive patients with early progressive RA were randomly assigned to double-blind 4 mg/kg TCZ+MTX, 8 mg/kg TCZ+MTX, 8 mg/kg TCZ+placebo or placebo+MTX for 104 weeks. Patients not rec...

2017
Yunda Huang Giuseppe Pantaleo Gonzalo Tapia Brittany Sanchez Lily Zhang Monica Trondsen Arnt-Ove Hovden Richard Pollard Jürgen Rockstroh Mats Ökvist Maja A. Sommerfelt

BACKGROUND In a placebo-controlled trial of the peptide-based therapeutic HIV-1 p24Gag vaccine candidate Vacc-4x, participants on combination antiretroviral therapy (cART) received six immunizations over 18weeks, followed by analytical treatment interruption (ATI) between weeks 28 and 52. Cell-mediated immune responses were investigated as predictors of Vacc-4x effect (VE) on viral load (VL) an...

Journal: :Journal of the American Academy of Dermatology 2014
Kenneth B Gordon Craig L Leonardi Mark Lebwohl Andrew Blauvelt Gregory S Cameron Daniel Braun Janelle Erickson Michael Heffernan

BACKGROUND Patients with moderate to severe plaque psoriasis demonstrated positive responses to ixekizumab, an anti-interleukin-17A monoclonal antibody, in a phase-II, randomized, placebo-controlled trial. OBJECTIVE We sought to evaluate long-term efficacy and safety of ixekizumab. METHODS After receiving 10, 25, 75, or 150 mg of ixekizumab or placebo during randomized, placebo-controlled t...

2016
Cristina Russo Fabio Cibella Pasquale Caponnetto Davide Campagna Marilena Maglia Evelise Frazzetto Enrico Mondati Massimo Caruso Riccardo Polosa

Stop smoking it is often associated to weight gain that is one of the most important causes for relapse. This is the first study to describe long-term changes in body weight in smokers invited to quit or reduce smoking by switching to ECs. Conventional cigarettes consumption and body weight were measured prospectively in a randomized controlled trial of smokers invited to switch to ECs. Post ce...

Journal: :medical journal of islamic republic of iran 0
esmat babadizavandy from the department of nursery and midwifery, mashhad university, mashhad, islamic republic of iran. ghodsih seyyedi alavi masomeh cordi

the purpose of this prospective study was to determine the effect of calcium supplementation in the incidence of hypertensive disorders of pregnancy (gestational hypertension and pre-eclampsia) in nulliparous and high risk women. 300 pregnant women in the 24th week of gestation at the beginning of the study were entered into a double-blind randomized trial. 143 of them who had a positive roll-o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید